PMID- 20863428 OWN - NLM STAT- MEDLINE DCOM- 20110228 LR - 20161125 IS - 1607-8454 (Electronic) IS - 1024-5332 (Linking) VI - 15 IP - 5 DP - 2010 Oct TI - Interstitial insertion of RARalpha gene into PML gene in a patient with acute promyelocytic leukemia (APL) lacking the classic t(15;17). PG - 332-7 LID - 10.1179/102453310X12647083621083 [doi] AB - The diagnosis of APL is based on clinical and morphological tests though the final diagnosis is at the molecular level. An accurate diagnosis is important as it mandates targeted therapy to improve survival. We report a case of APL without t(15;17) in conventional cytogenetic study and with initially negative fluorescence in situ hybridization (FISH) study on cells in interphase. Reverse transcription polymerase chain reaction (RT-PCR) for the promyelocytic/retinoic acid receptor alpha gene (PML/RARalpha) fusion oncogene proved the clinical diagnosis as well as FISH study on cells in metaphase. The cause was a cryptic translocation of the RARalpha gene into PML. We reviewed 36 additional cases of APL diagnosed in our hospital since 1992. This was the only case that failed to show t(15;17) in cytogenetics. However, three cases with t(15;17) in cytogenetics had negative RT-PCR for PML/RARalpha. Our case emphasizes that cytogenetics, FISH and RT-PCR studies are complementary studies for the molecular diagnosis of APL. FAU - Goldschmidt, Neta AU - Goldschmidt N AD - Department of Hematology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel. neta@hadassah.org.il FAU - Yehuda-Gafni, Orly AU - Yehuda-Gafni O FAU - Abeliovich, Deborah AU - Abeliovich D FAU - Slyusarevsky, Elena AU - Slyusarevsky E FAU - Rund, Deborah AU - Rund D LA - eng PT - Case Reports PT - Journal Article PL - England TA - Hematology JT - Hematology (Amsterdam, Netherlands) JID - 9708388 RN - 0 (Nuclear Proteins) RN - 0 (Oncogene Proteins, Fusion) RN - 0 (Promyelocytic Leukemia Protein) RN - 0 (RARA protein, human) RN - 0 (Receptors, Retinoic Acid) RN - 0 (Retinoic Acid Receptor alpha) RN - 0 (Transcription Factors) RN - 0 (Tumor Suppressor Proteins) RN - 0 (promyelocytic leukemia-retinoic acid receptor alpha fusion oncoprotein) RN - 143220-95-5 (PML protein, human) SB - IM MH - Chromosomes, Human, Pair 15 MH - Chromosomes, Human, Pair 17 MH - Female MH - Humans MH - In Situ Hybridization, Fluorescence MH - Karyotyping MH - Leukemia, Promyelocytic, Acute/diagnosis/*genetics MH - Middle Aged MH - Mutagenesis, Insertional MH - Nuclear Proteins/*genetics MH - Oncogene Proteins, Fusion/*genetics MH - Promyelocytic Leukemia Protein MH - Receptors, Retinoic Acid/*genetics MH - Retinoic Acid Receptor alpha MH - Reverse Transcriptase Polymerase Chain Reaction MH - Transcription Factors/*genetics MH - Translocation, Genetic/genetics MH - Tumor Suppressor Proteins/*genetics EDAT- 2010/09/25 06:00 MHDA- 2011/03/01 06:00 CRDT- 2010/09/25 06:00 PHST- 2010/09/25 06:00 [entrez] PHST- 2010/09/25 06:00 [pubmed] PHST- 2011/03/01 06:00 [medline] AID - 10.1179/102453310X12647083621083 [doi] PST - ppublish SO - Hematology. 2010 Oct;15(5):332-7. doi: 10.1179/102453310X12647083621083.